{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:22:43Z","timestamp":1786112563101,"version":"build-2736575974"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82101958"],"award-info":[{"award-number":["82101958"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271906"],"award-info":[{"award-number":["82271906"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2024JJ5460"],"award-info":[{"award-number":["2024JJ5460"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2024JJ6675"],"award-info":[{"award-number":["2024JJ6675"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Changsha Municipal Natural Science Foundation","award":["kq2007073"],"award-info":[{"award-number":["kq2007073"]}]},{"name":"Hunan Science and Technology major project of Birth Defect Cooperative Control","award":["2019SK1010"],"award-info":[{"award-number":["2019SK1010"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-06115-0","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:16:47Z","timestamp":1785943007000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["FYN, a Novel Target of Fragile X Mental Retardation Protein, Potentially Underlies ERK1\/2 Hyperactivation in Fragile X Syndrome"],"prefix":"10.1007","volume":"63","author":[{"given":"Wen","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YanPing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranhui","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuping","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"issue":"4","key":"6115_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41583-021-00432-0","volume":"22","author":"JD Richter","year":"2021","unstructured":"Richter JD, Zhao X (2021) The molecular biology of FMRP: new insights into fragile X syndrome. Nat Rev Neurosci 22(4):209\u2013222. https:\/\/doi.org\/10.1038\/s41583-021-00432-0","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"6115_CR2","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.neuron.2019.02.041","volume":"101","author":"C Bagni","year":"2019","unstructured":"Bagni C, Zukin RS (2019) A synaptic perspective of fragile X syndrome and autism spectrum disorders. Neuron 101(6):1070\u20131088. https:\/\/doi.org\/10.1016\/j.neuron.2019.02.041","journal-title":"Neuron"},{"issue":"4","key":"6115_CR3","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/dneu.22417","volume":"77","author":"V Mart\u00ednez-Cerde\u00f1o","year":"2016","unstructured":"Mart\u00ednez-Cerde\u00f1o V (2016) Dendrite and spine modifications in autism and related neurodevelopmental disorders in patients and animal models. Dev Neurobiol 77(4):393\u2013404. https:\/\/doi.org\/10.1002\/dneu.22417","journal-title":"Dev Neurobiol"},{"key":"6115_CR4","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.neuroscience.2012.03.049","volume":"251","author":"CX He","year":"2013","unstructured":"He CX, Portera-Cailliau C (2013) The trouble with spines in fragile X syndrome: density, maturity and plasticity. Neuroscience 251:120\u2013128. https:\/\/doi.org\/10.1016\/j.neuroscience.2012.03.049","journal-title":"Neuroscience"},{"key":"6115_CR5","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.neubiorev.2021.10.009","volume":"131","author":"JD Iroegbu","year":"2021","unstructured":"Iroegbu JD, Ijomone OK, Femi-Akinlosotu OM, Ijomone OM (2021) ERK\/MAPK signalling in the developing brain: perturbations and consequences. Neurosci Biobehav Rev 131:792\u2013805. https:\/\/doi.org\/10.1016\/j.neubiorev.2021.10.009","journal-title":"Neurosci Biobehav Rev"},{"issue":"4","key":"6115_CR6","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.neuron.2006.07.005","volume":"51","author":"L Hou","year":"2006","unstructured":"Hou L, Antion MD, Hu D, Spencer CM, Paylor R, Klann E (2006) Dynamic translational and proteasomal regulation of fragile X mental retardation protein controls mGluR-dependent long-term depression. Neuron 51(4):441\u2013454. https:\/\/doi.org\/10.1016\/j.neuron.2006.07.005","journal-title":"Neuron"},{"issue":"51","key":"6115_CR7","doi-asserted-by":"publisher","first-page":"13958","DOI":"10.1523\/jneurosci.4383-07.2007","volume":"27","author":"TJ Price","year":"2007","unstructured":"Price TJ, Rashid MH, Millecamps M, Sanoja R, Entrena JM, Cervero F (2007) Decreased nociceptive sensitization in mice lacking the fragile X mental retardation protein: role of mGluR1\/5 and mTOR. J Neurosci 27(51):13958\u201313967. https:\/\/doi.org\/10.1523\/jneurosci.4383-07.2007","journal-title":"J Neurosci"},{"issue":"1","key":"6115_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neuron.2012.03.009","volume":"74","author":"A Michalon","year":"2012","unstructured":"Michalon A, Sidorov M, Ballard TM, Ozmen L, Spooren W, Wettstein JG, Jaeschke G, Bear MF, et al. (2012) Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice. Neuron 74(1):49\u201356. https:\/\/doi.org\/10.1016\/j.neuron.2012.03.009","journal-title":"Neuron"},{"issue":"4","key":"6115_CR9","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/j.1471-4159.2012.07722.x","volume":"121","author":"X Wang","year":"2012","unstructured":"Wang X, Snape M, Klann E, Stone JG, Singh A, Petersen RB, Castellani RJ, Casadesus G, et al. (2012) Activation of the extracellular signal-regulated kinase pathway contributes to the behavioral deficit of fragile X-syndrome. J Neurochem 121(4):672\u2013679. https:\/\/doi.org\/10.1111\/j.1471-4159.2012.07722.x","journal-title":"J Neurochem"},{"issue":"2","key":"6115_CR10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.neuron.2012.01.034","volume":"77","author":"EK Osterweil","year":"2013","unstructured":"Osterweil EK, Chuang S-C, Chubykin AA, Sidorov M, Bianchi R, Wong RKS, Bear MF (2013) Lovastatin corrects excess protein synthesis and prevents epileptogenesis in a mouse model of fragile X syndrome. Neuron 77(2):243\u2013250. https:\/\/doi.org\/10.1016\/j.neuron.2012.01.034","journal-title":"Neuron"},{"issue":"6","key":"6115_CR11","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3109\/1354750x.2016.1160289","volume":"21","author":"D Pellerin","year":"2016","unstructured":"Pellerin D, \u00c7aku A, Fradet M, Bouvier P, Dub\u00e9 J, Corbin F (2016) Lovastatin corrects ERK pathway hyperactivation in fragile X syndrome: potential of platelet\u2019s signaling cascades as new outcome measures in clinical trials. Biomarkers 21(6):497\u2013508. https:\/\/doi.org\/10.3109\/1354750x.2016.1160289","journal-title":"Biomarkers"},{"key":"6115_CR12","doi-asserted-by":"publisher","DOI":"10.1523\/eneuro.0097-19.2019","author":"M Muscas","year":"2019","unstructured":"Muscas M, Louros SR, Osterweil EK (2019) Lovastatin, not simvastatin, corrects core phenotypes in the fragile X mouse model. eNeuro. https:\/\/doi.org\/10.1523\/eneuro.0097-19.2019","journal-title":"eNeuro"},{"issue":"11","key":"6115_CR13","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1002\/ajmg.a.36750","volume":"164","author":"A \u00c7aku","year":"2014","unstructured":"\u00c7aku A, Pellerin D, Bouvier P, Riou E, Corbin F (2014) Effect of lovastatin on behavior in children and adults with fragile X syndrome: an open\u2010label study. Am J Med Genet A 164(11):2834\u20132842. https:\/\/doi.org\/10.1002\/ajmg.a.36750","journal-title":"Am J Med Genet A"},{"issue":"1","key":"6115_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001969","volume":"21","author":"SN Leahy","year":"2023","unstructured":"Leahy SN, Song C, Vita DJ, Broadie K (2023) FMRP activity and control of Csw\/SHP2 translation regulate MAPK-dependent synaptic transmission. PLoS Biol 21(1):e3001969. https:\/\/doi.org\/10.1371\/journal.pbio.3001969","journal-title":"PLoS Biol"},{"issue":"31","key":"6115_CR15","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2407546121","volume":"121","author":"JH Choi","year":"2024","unstructured":"Choi JH, Marsal-Garc\u00eda L, Peraldi E, Walters C, Huang Z, Gantois I, Sonenberg N (2024) Early metformin treatment: an effective approach for targeting fragile X syndrome pathophysiology. Proc Natl Acad Sci U S A 121(31):e2407546121. https:\/\/doi.org\/10.1073\/pnas.2407546121","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5009","key":"6115_CR16","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1126\/science.252.5009.1097","volume":"252","author":"IRF Oberl\u00e9","year":"1991","unstructured":"Oberl\u00e9 IRF, Heitz D, Kretz C, Devys D, Hanauer A, Bou\u00e9 J, Bertheas MF, Mandel JL (1991) Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252(5009):1097\u20131102. https:\/\/doi.org\/10.1126\/science.252.5009.1097","journal-title":"Science"},{"issue":"8","key":"6115_CR17","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1038\/s41588-025-02255-6","volume":"57","author":"A Gadban","year":"2025","unstructured":"Gadban A, Gunapala KM, Taylor V, Benvenisty N (2025) Therapeutic strategies for fragile X syndrome and implications for other gene-silencing disorders. Nat Genet 57(8):1812\u20131822. https:\/\/doi.org\/10.1038\/s41588-025-02255-6","journal-title":"Nat Genet"},{"issue":"2","key":"6115_CR18","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.neuron.2008.10.004","volume":"60","author":"GJ Bassell","year":"2008","unstructured":"Bassell GJ, Warren ST (2008) Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron 60(2):201\u2013214. https:\/\/doi.org\/10.1016\/j.neuron.2008.10.004","journal-title":"Neuron"},{"issue":"12","key":"6115_CR19","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1038\/s41556-024-01544-2","volume":"26","author":"AR Fenton","year":"2024","unstructured":"Fenton AR, Peng R, Bond C, Hugelier S, Lakadamyali M, Chang Y-W, Holzbaur ELF, Jongens TA (2024) FMRP regulates MFF translation to locally direct mitochondrial fission in neurons. Nat Cell Biol 26(12):2061\u20132074. https:\/\/doi.org\/10.1038\/s41556-024-01544-2","journal-title":"Nat Cell Biol"},{"issue":"11","key":"6115_CR20","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1038\/nn.3379","volume":"16","author":"JC Darnell","year":"2013","unstructured":"Darnell JC, Klann E (2013) The translation of translational control by FMRP: therapeutic targets for FXS. Nat Neurosci 16(11):1530\u20131536. https:\/\/doi.org\/10.1038\/nn.3379","journal-title":"Nat Neurosci"},{"issue":"2","key":"6115_CR21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.cell.2011.06.013","volume":"146","author":"C Darnell Jennifer","year":"2011","unstructured":"Darnell Jennifer C, Van Driesche SJ, Zhang C, Hung Ka Ying S, Mele A, Fraser Claire E, Stone Elizabeth F, Chen C, et al. (2011) FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism. Cell 146(2):247\u2013261. https:\/\/doi.org\/10.1016\/j.cell.2011.06.013","journal-title":"Cell"},{"key":"6115_CR22","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.brainres.2011.07.059","volume":"1415","author":"LW Babus","year":"2011","unstructured":"Babus LW, Little EM, Keenoy KE, Minami SS, Chen E, Song JM, Caviness J, Koo S-Y, et al. (2011) Decreased dendritic spine density and abnormal spine morphology in Fyn knockout mice. Brain Res 1415:96\u2013102. https:\/\/doi.org\/10.1016\/j.brainres.2011.07.059","journal-title":"Brain Res"},{"key":"6115_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cells11193063","author":"L F\u00e3o","year":"2022","unstructured":"F\u00e3o L, Coelho P, Rodrigues RJ, Rego AC (2022) Restored Fyn levels in Huntington\u2019s disease contributes to enhanced synaptic GluN2B-composed NMDA receptors and CREB activity. Cells. https:\/\/doi.org\/10.3390\/cells11193063","journal-title":"Cells"},{"issue":"30","key":"6115_CR24","doi-asserted-by":"publisher","first-page":"21003","DOI":"10.1074\/jbc.274.30.21003","volume":"274","author":"J-i Abe","year":"1999","unstructured":"Abe J-i, Berk BC (1999) Fyn and JAK2 mediate Ras activation by reactive oxygen species. J Biol Chem 274(30):21003\u201321010. https:\/\/doi.org\/10.1074\/jbc.274.30.21003","journal-title":"J Biol Chem"},{"issue":"22","key":"6115_CR25","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1007\/s00018-010-0447-y","volume":"67","author":"CM Stern","year":"2010","unstructured":"Stern CM, Mermelstein PG (2010) Caveolin regulation of neuronal intracellular signaling. Cell Mol Life Sci 67(22):3785\u20133795. https:\/\/doi.org\/10.1007\/s00018-010-0447-y","journal-title":"Cell Mol Life Sci"},{"issue":"23","key":"6115_CR26","doi-asserted-by":"publisher","first-page":"9659","DOI":"10.1158\/0008-5472.Can-10-2034","volume":"70","author":"N Fenouille","year":"2010","unstructured":"Fenouille N, Puissant A, Dufies M, Robert G, Jacquel A, Ohanna M, Deckert M, Pasquet J-M, et al. (2010) Persistent activation of the Fyn\/ERK kinase signaling axis mediates imatinib resistance in chronic myelogenous leukemia cells through upregulation of intracellular SPARC. Cancer Res 70(23):9659\u20139670. https:\/\/doi.org\/10.1158\/0008-5472.Can-10-2034","journal-title":"Cancer Res"},{"key":"6115_CR27","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.expneurol.2013.06.014","volume":"248","author":"MJ P\u00e9rez","year":"2013","unstructured":"P\u00e9rez MJ, Fernandez N, Pasquini JM (2013) Oligodendrocyte differentiation and signaling after transferrin internalization: a mechanism of action. Exp Neurol 248:262\u2013274. https:\/\/doi.org\/10.1016\/j.expneurol.2013.06.014","journal-title":"Exp Neurol"},{"issue":"5","key":"6115_CR28","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/s41380-024-02418-7","volume":"29","author":"V Stamenkovic","year":"2024","unstructured":"Stamenkovic V, Lautz JD, Harsh FM, Smith SEP (2024) SRC family kinase inhibition rescues molecular and behavioral phenotypes, but not protein interaction network dynamics, in a mouse model of fragile X syndrome. Mol Psychiatry 29(5):1392\u20131405. https:\/\/doi.org\/10.1038\/s41380-024-02418-7","journal-title":"Mol Psychiatry"},{"issue":"32","key":"6115_CR29","doi-asserted-by":"publisher","first-page":"10624","DOI":"10.1523\/JNEUROSCI.0402-10.2010","volume":"30","author":"C Gross","year":"2010","unstructured":"Gross C, Nakamoto M, Yao X, Chan CB, Yim SY, Ye K, Warren ST, Bassell GJ (2010) Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome. J Neurosci 30(32):10624\u201310638. https:\/\/doi.org\/10.1523\/JNEUROSCI.0402-10.2010","journal-title":"J Neurosci"},{"issue":"3","key":"6115_CR30","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1054\/modi.2000.9404","volume":"5","author":"B Gold","year":"2000","unstructured":"Gold B, Radu D, Balanko A, Chiang CS (2000) Diagnosis of Fragile X syndrome by Southern blot hybridization using a chemiluminescent probe: a laboratory protocol. Molecular Diagnosis\u202f: J Devot Understanding Human Dis Through Clin App Molecul Biol 5(3):169\u2013178. https:\/\/doi.org\/10.1054\/modi.2000.9404","journal-title":"Molecular Diagnosis : J Devot Understanding Human Dis Through Clin App Molecul Biol"},{"issue":"3","key":"6115_CR31","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1534\/genetics.108.088435","volume":"179","author":"SM Rollmann","year":"2008","unstructured":"Rollmann SM, Zwarts L, Edwards AC, Yamamoto A, Callaerts P, Norga K, Mackay TF, Anholt RR (2008) Pleiotropic effects of Drosophila neuralized on complex behaviors and brain structure. Genetics 179(3):1327\u20131336. https:\/\/doi.org\/10.1534\/genetics.108.088435","journal-title":"Genetics"},{"issue":"25","key":"6115_CR32","doi-asserted-by":"publisher","first-page":"5798","DOI":"10.1523\/jneurosci.1102-04.2004","volume":"24","author":"CI Michel","year":"2004","unstructured":"Michel CI, Kraft R, Restifo LL (2004) Defective neuronal development in the mushroom bodies of Drosophila fragile X mental retardation 1 mutants. J Neurosci 24(25):5798\u20135809. https:\/\/doi.org\/10.1523\/jneurosci.1102-04.2004","journal-title":"J Neurosci"},{"issue":"5","key":"6115_CR33","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.neuron.2005.01.038","volume":"45","author":"SM McBride","year":"2005","unstructured":"McBride SM, Choi CH, Wang Y, Liebelt D, Braunstein E, Ferreiro D, Sehgal A, Siwicki KK, et al. (2005) Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome. Neuron 45(5):753\u2013764. https:\/\/doi.org\/10.1016\/j.neuron.2005.01.038","journal-title":"Neuron"},{"issue":"4","key":"6115_CR34","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nchembio.78","volume":"4","author":"S Chang","year":"2008","unstructured":"Chang S, Bray SM, Li Z, Zarnescu DC, He C, Jin P, Warren ST (2008) Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila. Nat Chem Biol 4(4):256\u2013263. https:\/\/doi.org\/10.1038\/nchembio.78","journal-title":"Nat Chem Biol"},{"issue":"7","key":"6115_CR35","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1073\/pnas.76.7.3430","volume":"76","author":"RW Siegel","year":"1979","unstructured":"Siegel RW, Hall JC (1979) Conditioned responses in courtship behavior of normal and mutant Drosophila. Proc Natl Acad Sci U S A 76(7):3430\u20133434. https:\/\/doi.org\/10.1073\/pnas.76.7.3430","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"6115_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0092-8674(94)90398-0","volume":"79","author":"T Tully","year":"1994","unstructured":"Tully T, Preat T, Boynton SC, Del Vecchio M (1994) Genetic dissection of consolidated memory in Drosophila. Cell 79(1):35\u201347. https:\/\/doi.org\/10.1016\/0092-8674(94)90398-0","journal-title":"Cell"},{"issue":"11","key":"6115_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027100","volume":"6","author":"JM Tauber","year":"2011","unstructured":"Tauber JM, Vanlandingham PA, Zhang B (2011) Elevated levels of the vesicular monoamine transporter and a novel repetitive behavior in the Drosophila model of fragile X syndrome. PLoS ONE 6(11):e27100. https:\/\/doi.org\/10.1371\/journal.pone.0027100","journal-title":"PLoS ONE"},{"issue":"1","key":"6115_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/01677063.2020.1833005","volume":"35","author":"DR Andrew","year":"2021","unstructured":"Andrew DR, Moe ME, Chen D, Tello JA, Doser RL, Conner WE, Ghuman JK, Restifo LL (2021) Spontaneous motor-behavior abnormalities in two Drosophila models of neurodevelopmental disorders. J Neurogenet 35(1):1\u201322. https:\/\/doi.org\/10.1080\/01677063.2020.1833005","journal-title":"J Neurogenet"},{"issue":"4","key":"6115_CR39","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1073\/pnas.0912540107","volume":"107","author":"A Kamsler","year":"2010","unstructured":"Kamsler A, McHugh TJ, Gerber D, Huang SY, Tonegawa S (2010) Presynaptic m1 muscarinic receptors are necessary for mGluR long-term depression in the hippocampus. Proc Natl Acad Sci U S A 107(4):1618\u20131623. https:\/\/doi.org\/10.1073\/pnas.0912540107","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"6115_CR40","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s11064-011-0691-z","volume":"37","author":"T Chen","year":"2012","unstructured":"Chen T, Cao L, Dong W, Luo P, Liu W, Qu Y, Fei Z (2012) Protective effects of mGluR5 positive modulators against traumatic neuronal injury through PKC-dependent activation of MEK\/ERK pathway. Neurochem Res 37(5):983\u2013990. https:\/\/doi.org\/10.1007\/s11064-011-0691-z","journal-title":"Neurochem Res"},{"issue":"4","key":"6115_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.116","volume":"5","author":"P Luo","year":"2014","unstructured":"Luo P, Chen T, Zhao Y, Zhang L, Yang Y, Liu W, Li S, Rao W, et al. (2014) Postsynaptic scaffold protein Homer 1a protects against traumatic brain injury via regulating group I metabotropic glutamate receptors. Cell Death Dis 5(4):e1174. https:\/\/doi.org\/10.1038\/cddis.2014.116","journal-title":"Cell Death Dis"},{"issue":"7","key":"6115_CR42","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1002\/ajmg.b.30765","volume":"147b","author":"N Weng","year":"2008","unstructured":"Weng N, Weiler IJ, Sumis A, Berry-Kravis E, Greenough WT (2008) Early-phase ERK activation as a biomarker for metabolic status in fragile X syndrome. Am J Med Genet B Neuropsychiatr Genet 147b(7):1253\u20131257. https:\/\/doi.org\/10.1002\/ajmg.b.30765","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"5","key":"6115_CR43","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.celrep.2015.03.060","volume":"11","author":"C Gross","year":"2015","unstructured":"Gross C, Chang CW, Kelly SM, Bhattacharya A, McBride SM, Danielson SW, Jiang MQ, Chan CB, et al. (2015) Increased expression of the PI3K enhancer PIKE mediates deficits in synaptic plasticity and behavior in fragile X syndrome. Cell Rep 11(5):727\u2013736. https:\/\/doi.org\/10.1016\/j.celrep.2015.03.060","journal-title":"Cell Rep"},{"key":"6115_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2022.114389","volume":"249","author":"L Chen","year":"2023","unstructured":"Chen L, Zhai L, Gao Y, Cui Z, Yu L, Zhu D, Tang H, Luo H (2023) Nrf2 affects hydroquinone-induces cell cycle arrest through the p16\/pRb signaling pathway and antioxidant enzymes. Ecotoxicol Environ Saf 249:114389. https:\/\/doi.org\/10.1016\/j.ecoenv.2022.114389","journal-title":"Ecotoxicol Environ Saf"},{"key":"6115_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094536","author":"SJ Annesley","year":"2021","unstructured":"Annesley SJ, Fisher PR (2021) Lymphoblastoid cell lines as models to study mitochondrial function in neurological disorders. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22094536","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6115_CR46","doi-asserted-by":"publisher","first-page":"336","DOI":"10.2119\/molmed.2011.00363","volume":"18","author":"C Gross","year":"2012","unstructured":"Gross C, Bassell GJ (2012) Excess protein synthesis in FXS patient lymphoblastoid cells can be rescued with a p110\u03b2-selective inhibitor. Molecul Med (Cambridge, Mass) 18(1):336\u2013345. https:\/\/doi.org\/10.2119\/molmed.2011.00363","journal-title":"Molecul Med (Cambridge, Mass)"},{"issue":"4","key":"6115_CR47","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/s0092-8674(01)00568-2","volume":"107","author":"V Brown","year":"2001","unstructured":"Brown V, Jin P, Ceman S, Darnell JC, O\u2019Donnell WT, Tenenbaum SA, Jin X, Feng Y, et al. (2001) Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 107(4):477\u2013487. https:\/\/doi.org\/10.1016\/s0092-8674(01)00568-2","journal-title":"Cell"},{"issue":"42","key":"6115_CR48","doi-asserted-by":"publisher","first-page":"15201","DOI":"10.1073\/pnas.0404995101","volume":"101","author":"R Lu","year":"2004","unstructured":"Lu R, Wang H, Liang Z, Ku L, O\u2019Donnell WT, Li W, Warren ST, Feng Y (2004) The fragile X protein controls microtubule-associated protein 1B translation and microtubule stability in brain neuron development. Proc Natl Acad Sci U S A 101(42):15201\u201315206. https:\/\/doi.org\/10.1073\/pnas.0404995101","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"6115_CR49","doi-asserted-by":"publisher","first-page":"5986","DOI":"10.1007\/s12035-021-02518-3","volume":"58","author":"B Guglietti","year":"2021","unstructured":"Guglietti B, Sivasankar S, Mustafa S, Corrigan F, Collins-Praino LE (2021) Fyn kinase activity and its role in neurodegenerative disease pathology: a potential universal target? Mol Neurobiol 58(11):5986\u20136005. https:\/\/doi.org\/10.1007\/s12035-021-02518-3","journal-title":"Mol Neurobiol"},{"key":"6115_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9200","volume":"6","author":"GS Brigidi","year":"2015","unstructured":"Brigidi GS, Santyr B, Shimell J, Jovellar B, Bamji SX (2015) Activity-regulated trafficking of the palmitoyl-acyl transferase DHHC5. Nat Commun 6:8200. https:\/\/doi.org\/10.1038\/ncomms9200","journal-title":"Nat Commun"},{"issue":"12","key":"6115_CR51","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.1523\/jneurosci.4989-14.2015","volume":"35","author":"DL Castillo-Carranza","year":"2015","unstructured":"Castillo-Carranza DL, Guerrero-Mu\u00f1oz MJ, Sengupta U, Hernandez C, Barrett AD, Dineley K, Kayed R (2015) Tau immunotherapy modulates both pathological tau and upstream amyloid pathology in an Alzheimer\u2019s disease mouse model. J Neurosci 35(12):4857\u20134868. https:\/\/doi.org\/10.1523\/jneurosci.4989-14.2015","journal-title":"J Neurosci"},{"issue":"5090","key":"6115_CR52","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1126\/science.1361685","volume":"258","author":"SG Grant","year":"1992","unstructured":"Grant SG, O\u2019Dell TJ, Karl KA, Stein PL, Soriano P, Kandel ER (1992) Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice. Science 258(5090):1903\u20131910. https:\/\/doi.org\/10.1126\/science.1361685","journal-title":"Science"},{"key":"6115_CR53","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqz030","author":"T Bland","year":"2020","unstructured":"Bland T, Zhu M, Dillon C, Sahin GS, Rodriguez-Llamas JL, Appleyard SM, Wayman GA (2020) Leptin controls glutamatergic synaptogenesis and NMDA-receptor trafficking via Fyn kinase regulation of NR2B. Endocrinology. https:\/\/doi.org\/10.1210\/endocr\/bqz030","journal-title":"Endocrinology"},{"issue":"13","key":"6115_CR54","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1038\/npp.2013.175","volume":"38","author":"X Xie","year":"2013","unstructured":"Xie X, Arguello AA, Wells AM, Reittinger AM, Fuchs RA (2013) Role of a hippocampal SRC-family kinase-mediated glutamatergic mechanism in drug context-induced cocaine seeking. Neuropsychopharmacology 38(13):2657\u20132665. https:\/\/doi.org\/10.1038\/npp.2013.175","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"6115_CR55","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1046\/j.1460-9568.1999.00407.x","volume":"11","author":"YF Lu","year":"1999","unstructured":"Lu YF, Kojima N, Tomizawa K, Moriwaki A, Matsushita M, Obata K, Matsui H (1999) Enhanced synaptic transmission and reduced threshold for LTP induction in fyn-transgenic mice. Eur J Neurosci 11(1):75\u201382. https:\/\/doi.org\/10.1046\/j.1460-9568.1999.00407.x","journal-title":"Eur J Neurosci"},{"issue":"2","key":"6115_CR56","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.neuron.2010.03.017","volume":"66","author":"BE Pfeiffer","year":"2010","unstructured":"Pfeiffer BE, Zang T, Wilkerson JR, Taniguchi M, Maksimova MA, Smith LN, Cowan CW, Huber KM (2010) Fragile X mental retardation protein is required for synapse elimination by the activity-dependent transcription factor MEF2. Neuron 66(2):191\u2013197. https:\/\/doi.org\/10.1016\/j.neuron.2010.03.017","journal-title":"Neuron"},{"issue":"22","key":"6115_CR57","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.1523\/jneurosci.1645-19.2020","volume":"40","author":"M Fukaya","year":"2020","unstructured":"Fukaya M, Sugawara T, Hara Y, Itakura M, Watanabe M, Sakagami H (2020) BRAG2a mediates mGluR-dependent AMPA receptor internalization at excitatory postsynapses through the interaction with PSD-95 and endophilin 3. J Neurosci 40(22):4277\u20134296. https:\/\/doi.org\/10.1523\/jneurosci.1645-19.2020","journal-title":"J Neurosci"},{"issue":"10","key":"6115_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1010438","volume":"18","author":"S Yamada","year":"2022","unstructured":"Yamada S, Mizukoshi T, Tokunaga A, Sakakibara SI (2022) Inka2, a novel Pak4 inhibitor, regulates actin dynamics in neuronal development. PLoS Genet 18(10):e1010438. https:\/\/doi.org\/10.1371\/journal.pgen.1010438","journal-title":"PLoS Genet"},{"issue":"8","key":"6115_CR59","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1523\/jneurosci.5196-05.2006","volume":"26","author":"JL Banko","year":"2006","unstructured":"Banko JL, Hou L, Poulin F, Sonenberg N, Klann E (2006) Regulation of eukaryotic initiation factor 4E by converging signaling pathways during metabotropic glutamate receptor-dependent long-term depression. J Neurosci 26(8):2167\u20132173. https:\/\/doi.org\/10.1523\/jneurosci.5196-05.2006","journal-title":"J Neurosci"},{"issue":"1","key":"6115_CR60","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s11689-020-09315-4","volume":"12","author":"AJ Thurman","year":"2020","unstructured":"Thurman AJ, Potter LA, Kim K, Tassone F, Banasik A, Potter SN, Bullard L, Nguyen V, et al. (2020) Controlled trial of lovastatin combined with an open-label treatment of a parent-implemented language intervention in youth with fragile X syndrome. J Neurodev Disord 12(1):12. https:\/\/doi.org\/10.1186\/s11689-020-09315-4","journal-title":"J Neurodev Disord"},{"issue":"2","key":"6115_CR61","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/cge.13039","volume":"93","author":"ABC Dy","year":"2018","unstructured":"Dy ABC, Tassone F, Eldeeb M, Salcedo-Arellano MJ, Tartaglia N, Hagerman R (2018) Metformin as targeted treatment in fragile X syndrome. Clin Genet 93(2):216\u2013222. https:\/\/doi.org\/10.1111\/cge.13039","journal-title":"Clin Genet"},{"issue":"11","key":"6115_CR62","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.956","volume":"7","author":"HMB Biag","year":"2019","unstructured":"Biag HMB, Potter LA, Wilkins V, Afzal S, Rosvall A, Salcedo-Arellano MJ, Rajaratnam A, Manzano-Nunez R, et al. (2019) Metformin treatment in young children with fragile X syndrome. Mol Genet Genomic Med 7(11):e956. https:\/\/doi.org\/10.1002\/mgg3.956","journal-title":"Mol Genet Genomic Med"},{"issue":"1","key":"6115_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-015-0119-0","volume":"7","author":"HB Nygaard","year":"2015","unstructured":"Nygaard HB, Wagner AF, Bowen GS, Good SP, MacAvoy MG, Strittmatter KA, Kaufman AC, Rosenberg BJ, et al. (2015) A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer\u2019s disease. Alzheimers Res Ther 7(1):35. https:\/\/doi.org\/10.1186\/s13195-015-0119-0","journal-title":"Alzheimers Res Ther"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06115-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06115-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06115-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:16:48Z","timestamp":1785943008000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06115-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6115"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06115-0","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures involving human lymphoblastoid cell lines were approved by the Ethics Committee of the School of Life Sciences, Central South University (Approval No.: 2021\u20132-2). Written informed consent was obtained from all participants, and all methods were performed in accordance with approved guidelines.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"811"}}